Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
65.90
-0.10 (-0.15%)
Apr 2, 2025, 11:11 AM CST

Shine-On BioMedical Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-9.52--
Cost of Revenue
-2.86--
Gross Profit
-6.67--
Selling, General & Admin
16.7915.1111.723.5
Research & Development
119.2854.246.97.99
Operating Expenses
136.0769.3518.6111.5
Operating Income
-136.07-62.68-18.61-11.5
Interest Expense
-0.03-0.01-0.03-0.02
Interest & Investment Income
16.2420.078.190.28
Currency Exchange Gain (Loss)
-7.69-11.37-
Other Non Operating Income (Expenses)
1.270.01--
Pretax Income
-118.59-34.94-21.82-11.24
Income Tax Expense
0.32.23-2.27-
Net Income
-118.89-37.17-19.54-11.24
Net Income to Common
-118.89-37.17-19.54-11.24
Shares Outstanding (Basic)
50504518
Shares Outstanding (Diluted)
50504518
Shares Change (YoY)
-0.11%9.67%145.83%-
EPS (Basic)
-2.39-0.75-0.43-0.61
EPS (Diluted)
-2.39-0.75-0.43-0.61
Free Cash Flow
-91.56-26.95-22.14-10.71
Free Cash Flow Per Share
-1.84-0.54-0.49-0.58
Gross Margin
-70.00%--
Operating Margin
--658.16%--
Profit Margin
--390.23%--
Free Cash Flow Margin
--282.94%--
EBITDA
-133.88-61.97-18.07-11.22
D&A For EBITDA
2.190.710.550.28
EBIT
-136.07-62.68-18.61-11.5
Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.